BSX logo

BSX
Boston Scientific Corp.

6,496
Mkt Cap
$151.72B
Volume
6.79M
52W High
$109.50
52W Low
$80.64
PE Ratio
54.76
BSX Fundamentals
Price
$101.11
Prev Close
$102.39
Open
$102.85
50D MA
$101.17
Beta
0.64
Avg. Volume
10.81M
EPS (Annual)
$1.25
P/B
6.76
Rev/Employee
$315,981.13
Loading...
Loading...
News
all
press releases
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Boston Scientific (BSX) is an Incredible Growth Stock: 3 Reasons Why
Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks·1d ago
News Placeholder
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·1d ago
News Placeholder
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Zacks·1d ago
News Placeholder
Boston Scientific (BSX) Recently Broke Out Above the 50-Day Moving Average
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
Zacks·1d ago
News Placeholder
Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors
Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?
Zacks·1d ago
News Placeholder
Company News for Oct 23, 2025
Companies in The News Are: BSX, ISRG, BCS, CB
Zacks·1d ago
News Placeholder
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.
Zacks·2d ago
News Placeholder
Boston Scientific (BSX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·2d ago
News Placeholder
Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up
BSX posts strong Q3 with 19% EPS growth, lifts 2025 sales and EPS outlook as shares edge higher.
Zacks·2d ago

Latest BSX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.